Hyun-Soo Kim
Vermögen: 43 Mio $ am 31.08.2026
Vermögen: 43 Mio $ am 31.08.2026
Hyun-Soo Kim currently works at Pharmicell Co., Ltd., as Chairman & Chief Executive Officer from 2009.
Mr. Kim also formerly worked at FCB Twelve Co., Ltd., as Co-CEO, Director, Head-Research & Development from 2009 to 2011 and FCB-Pharmicell Co., Ltd., as Chief Executive Officer & Director from 2010 to 2011.
Mr. Kim received his undergraduate degree from Yonsei University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMICELL CO., LTD 8.85% | 16.06.2026 | 5’309’547 ( 8.85% ) | 43 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMICELL CO., LTD. | Vorstandsvorsitzender | 19.08.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | Präsident | 06.10.2011 |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | Präsident | 27.06.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | Consumer Non-Durables |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | Commercial Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmicell Co., Ltd.
Pharmicell Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops stem cell based pharmaceuticals and technologies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen